Figure 1From: Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neuronsSystemic BMD does not affect IOP. Ocular pressure in mmHg as measured using TonoLab following laser photocoagulation of episcleral veins at two time points (arrows). Systemic BMD (1 mg/kg/day) delivered via subcutaneous osmotic pump did not affect IOP for control or OHT eyes compared to vehicle treatment (p ≥ 0.6; mean ± SEM; n = 16 eyes per group).Back to article page